Compounds and methods for treating protein aggregation diseases

A compound, or a pharmaceutically acceptable salt thereof, having the formula:

• wherein
• n is 0 or 1;
• R1.1 and R1.2 are independently hydrogen, halogen, —C(O)NR1AR1B, or —NR1AC(O)R1C;
• R2.1 and R2.2 are independently hydrogen, halogen, —CX23, —CHX22, —CH2X2, —OCX23, —OCH2X2, —OCHX22, —CN, —SOn2R2D, —SOv2NR2AR2B, —NR2CNR2AR2B, —ONR2AR2B, —NR2CC(O)NR2AR2B, —N(O)m2, —NR2AR2B, —C(O)R2C, —C(O) OR2C, —OC(O)R2C, —OC(O) OR2C, —C(O)NR2AR2B, —OC(O)NR2AR2B, —OR2D, —SR2D, —NR2ASO2R2D, —NR2AC(O)R2C, —NR2AC(O)OR2C, —NR2AOR2C, —SF5, —N3, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;
• R1A, R1B, R1C, R2A, R2B, R2C, and R2D are independently hydrogen, —CCl3, —CBr3, —CF3, —CI3, —CHCl2, —CHBr2, —CHF2, —CHI2, —CH2Cl, —CH2Br, —CH2F, —CH2I, —CN, —OH, —NH2, —COOH, —CONH2, —OCCl3, —OCF3, —OCBr3, —OCI3, —OCHCl2, —OCHBr2, —OCHI2, —OCHF2, —OCH2Cl, —OCH2Br, —OCH2I, —OCH2F, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;
• each X2 is independently —F, —Cl, —Br, or —I;
• n2 is an integer from 0 to 4;
• and
• m2 and v2 are independently 1 or 2;
• wherein at least one of R1.1 and R1.2 is not hydrogen;
• and
• wherein the compound is not: